Pfm Health Sciences, Lp filed its 13F report for Q4 2025 on February 17, 2026. The portfolio totaled 1 B reflecting a -22.88% change from the prior quarter, spanning 78 assets. The top 10 holdings comprised 42.6% of the portfolio, with Financials as the largest sector allocation. Quarterly activity included 30 new positions and 20 complete exits.
Items:
Total Value:
| Issuer Name | Class | Value | Shares | Option Type |
|---|
Pfm Health Sciences submitted their Form 13F-HR for the Q4 2025 period on 02/17/2026. This was the only submission for the quarter.
In the Q4 2025 filing, Pfm Health Sciences reported a managed portfolio value of 1 B, consisting of 78 individual positions.
This page displays the raw filing documents. To see which stocks Pfm Health Sciences bought or sold during Q4 2025, please visit Pfm Health Sciences's Portfolio Analysis page.